INFLUENZA PREVENTION
Clinical trials for INFLUENZA PREVENTION explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA PREVENTION trials appear
Sign up with your email to follow new studies for INFLUENZA PREVENTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental flu vaccine enters human testing
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests an experimental flu vaccine called FluMos-v2, with or without an adjuvant (ALFQ), in 45 healthy adults aged 18-50. Participants receive two shots four months apart and are followed for 15 months. The goal is to check safety and how well the vaccine tr…
Matched conditions: INFLUENZA PREVENTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 23, 2026 00:00 UTC
-
New flu vaccine trial aims for stronger, Longer-Lasting protection
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study tests a new flu vaccine (STEMos1) in 56 healthy adults aged 18-50. Half of the participants get the vaccine with an adjuvant (a substance that boosts the immune response), and half get it without. The goal is to check safety and how well the vaccine trigger…
Matched conditions: INFLUENZA PREVENTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 23, 2026 00:00 UTC